Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients

Study ID: NCT03686657
Start Date: 2025-10-10
End Date: 2029-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

115

Intervention / Treatment

Metformin

Val, Cel and Met XR Low

Val, Cel and Met XR High

Sponsor

ARKAY Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers

Study ID: NCT06917482
Start Date: 2025-06-30
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

BW-40202 injection

Sodium Chloride

Sponsor

Shanghai Argo Biopharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP

Study ID: NCT06804382
Start Date: 2027-04-01
End Date: 2030-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Academic detailing

Sponsor

Boston Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Understanding How Cigarette Direct Mail Marketing Influences Smoking Behaviors Among High and Low Socioeconomic Status Young Adult Smokers

Study ID: NCT02974582
Start Date: 2025-05-10
End Date: 2027-10-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

530

Intervention / Treatment

Exposure to smoking advertising with coupon

Exposure to smoking advertising without coupons

Exposure to non health related images

Sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Source: clinicaltrials.gov

Share:
Add to list

Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung Adenocarcinoma

Study ID: NCT06918782
Start Date: 2025-05-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

47

Intervention / Treatment

Osimertinib plus platinum doublet chemotherapy

Sponsor

The University of Hong Kong

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

Study ID: NCT06817382
Start Date: 2025-05-31
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

INS1201

Sponsor

Insmed Gene Therapy LLC

Source: clinicaltrials.gov

Share:
Add to list

Resilient HIV Implementation Science With SGM Youths Using Evidence

Study ID: NCT06350682
Start Date: 2025-05
End Date: 2028-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1500

Intervention / Treatment

HealthMPowerment (HMP)

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers

Study ID: NCT04762082
Start Date: 2025-05-01
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Tadalafil 10 mg

Sponsor

Seattle Gummy Company

Source: clinicaltrials.gov

Share:
Add to list

COPEWeb Training for Providers

Study ID: NCT05812131
Start Date: 2025-05-01
End Date: 2027-04-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

248

Intervention / Treatment

COPEWeb online training

COPE In Person

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Caesarean Section

Study ID: NCT06797973
Start Date: 2025-06-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

1312

Intervention / Treatment

Intrathecal Morphine

Placebo (Sodium Chloride Injection, 0.9%)

Sponsor

Zealand University Hospital

Source: clinicaltrials.gov

Share:
Add to list